Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Byrd

Showing results (731-740 of 903) with videos related to

Pageof 91
Sort By:
Cancer Immunology Research|July 21, 2017
MICA-Expressing Monocytes Enhance Natural Killer Cell Fc Receptor-Mediated Antitumor FunctionsAmanda R Campbell, Megan C Duggan, Lorena P Suarez-Kelly, et al.
British Journal of Haematology|October 22, 2016
Genomics of primary chemoresistance and remission induction failure in paediatric and adult acute myeloid leukaemiaFiona C Brown, Paolo Cifani, Esther Drill, et al.
Leukemia Research|March 26, 2015
Final results of EFC6663: a multicenter, international, phase 2 study of alvocidib for patients with fludarabine-refractory chronic lymphocytic leukemiaMark C Lanasa, Leslie Andritsos, Jennifer R Brown, et al.
Blood|October 5, 2012
Selective inhibitors of nuclear export show that CRM1/XPO1 is a target in chronic lymphocytic leukemiaRosa Lapalombella, Qingxiang Sun, Katie Williams, et al.
Cancer Genetics and Cytogenetics|December 16, 2010
Standardization of fluorescence in situ hybridization studies on chronic lymphocytic leukemia (CLL) blood and marrow cells by the CLL Research ConsortiumStephanie A Smoley, Daniel L Van Dyke, Neil E Kay, et al.
Leukemia Research|July 31, 2007
Expression of TCL-1 as a potential prognostic factor for treatment outcome in B-cell chronic lymphocytic leukemiaRebekah L Browning, Susan M Geyer, Amy J Johnson, et al.
Blood|December 8, 2009
Lenalidomide treatment promotes CD154 expression on CLL cells and enhances production of antibodies by normal B cells through a PI3-kinase-dependent pathwayRosa Lapalombella, Leslie Andritsos, Qing Liu, et al.
Blood Advances|March 8, 2021
Gene expression signature predicts relapse in adult patients with cytogenetically normal acute myeloid leukemiaChristopher J Walker, Krzysztof Mrózek, Hatice Gulcin Ozer, et al.
The Journal of Experimental Medicine|December 26, 2001
Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemiaA Rosenwald, A A Alizadeh, G Widhopf, et al.
Blood Advances|February 10, 2019
Anti-BAFF-R antibody VAY-736 demonstrates promising preclinical activity in CLL and enhances effectiveness of ibrutinibEmily M McWilliams, Christopher R Lucas, Timothy Chen, et al.
Pageof 91

Showing results (731-740 of 903) with videos related to

Sort By:
Pageof 91
Cancer Immunology Research|July 21, 2017
MICA-Expressing Monocytes Enhance Natural Killer Cell Fc Receptor-Mediated Antitumor FunctionsAmanda R Campbell, Megan C Duggan, Lorena P Suarez-Kelly, et al.
British Journal of Haematology|October 22, 2016
Genomics of primary chemoresistance and remission induction failure in paediatric and adult acute myeloid leukaemiaFiona C Brown, Paolo Cifani, Esther Drill, et al.
Leukemia Research|March 26, 2015
Final results of EFC6663: a multicenter, international, phase 2 study of alvocidib for patients with fludarabine-refractory chronic lymphocytic leukemiaMark C Lanasa, Leslie Andritsos, Jennifer R Brown, et al.
Blood|October 5, 2012
Selective inhibitors of nuclear export show that CRM1/XPO1 is a target in chronic lymphocytic leukemiaRosa Lapalombella, Qingxiang Sun, Katie Williams, et al.
Cancer Genetics and Cytogenetics|December 16, 2010
Standardization of fluorescence in situ hybridization studies on chronic lymphocytic leukemia (CLL) blood and marrow cells by the CLL Research ConsortiumStephanie A Smoley, Daniel L Van Dyke, Neil E Kay, et al.
Leukemia Research|July 31, 2007
Expression of TCL-1 as a potential prognostic factor for treatment outcome in B-cell chronic lymphocytic leukemiaRebekah L Browning, Susan M Geyer, Amy J Johnson, et al.
Blood|December 8, 2009
Lenalidomide treatment promotes CD154 expression on CLL cells and enhances production of antibodies by normal B cells through a PI3-kinase-dependent pathwayRosa Lapalombella, Leslie Andritsos, Qing Liu, et al.
Blood Advances|March 8, 2021
Gene expression signature predicts relapse in adult patients with cytogenetically normal acute myeloid leukemiaChristopher J Walker, Krzysztof Mrózek, Hatice Gulcin Ozer, et al.
The Journal of Experimental Medicine|December 26, 2001
Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemiaA Rosenwald, A A Alizadeh, G Widhopf, et al.
Blood Advances|February 10, 2019
Anti-BAFF-R antibody VAY-736 demonstrates promising preclinical activity in CLL and enhances effectiveness of ibrutinibEmily M McWilliams, Christopher R Lucas, Timothy Chen, et al.
Pageof 91